Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19

L Tang, Y Jiang, M Zhu, L Chen, X Zhou, C Zhou… - Frontiers of …, 2020 - Springer
… Mesenchymal stem cell (MSC) therapy is the immediate treatment used for patients with
severe cases of COVID-19. Herein, we describe two confirmed cases of COVID-19 in Wuhan to …

[HTML][HTML] Placenta-derived mesenchymal stem cells (P-MSCs) for COVID-19 pneumonia—a regenerative dogma

SE Siddesh, DM Gowda, R Jain, A Gulati… - Stem cell …, 2021 - ncbi.nlm.nih.gov
… by lymphocytes, dendritic cells, and macrophages … COVID-19 infection (13). This research
article provides an overview of how placental stem cells render immune privilege in COVID-19

COVID-19 and its therapeutics: special emphasis on mesenchymal stem cells based therapy

YK Verma, R Verma, N Tyagi, A Behl, S Kumar… - Stem cell reviews and …, 2021 - Springer
… role in abating the severity of COVID-19. This review … Stem Cells (MSCs) based therapy
alone or in combination with other therapeutics as an attractive curative approach for COVID-19

Umbilical cord blood-derived mesenchymal stem cells in treating a critically ill COVID-19 patient

J Tao, Y Nie, H Wu, L Cheng, Y Qiu, J Fu… - The Journal of Infection in …, 2020 - jidc.org
… Compared to BM-MSCs, umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs…
for critically ill cases with COVID-19. In this study, we reported one COVID-19 case of critical …

Safety and efficacy of mesenchymal stem cells in COVID19 patients: A systematic review and meta‐analysis

C Yan, M Hu, R Dai - Immunity, Inflammation and Disease, 2023 - Wiley Online Library
Coronavirus disease-19 (COVID-19) is a zoonotic disease … the COVID-19 pandemic and
persist problems make COVID-19stem cells (MSCs) therapy efficacy for COVID-19 is debatable…

[HTML][HTML] … study of mesenchymal stem cell treatment for acute respiratory distress syndrome induced by epidemic influenza A (H7N9) infection: a hint for COVID-19 …

J Chen, C Hu, L Chen, L Tang, Y Zhu, X Xu, L Chen… - Engineering, 2020 - Elsevier
… Transplantation of mesenchymal stem cells (MSCs) is a promising … Because H7N9 and the
coronavirus disease 2019 (COVID-19) … could be a possible alternative for treating COVID-19. …

'primed'mesenchymal stem cells: a potential novel therapeutic for COVID19 patients

SS Raza, P Seth, MA Khan - Stem Cell Reviews and Reports, 2021 - Springer
… The data of hospitalized COVID19 patients, especially those … , we propose ‘Primed’
Mesenchymal Stem Cells (MSCs) as a … approach to improve the responses of COVID19 patients. …

Results and prospects of using activator of hematopoietic stem cell differentiation in complex therapy for patients with COVID-19

VK Khavinson, BI Kuznik, SV Trofimova… - Stem Cell Reviews and …, 2021 - Springer
… Recently, there have been publications that mesenchymal stem cells (MSCs) can … COVID-19.
In addition, it was revealed that NK cells are able to exert a cytotoxic effect on infected cells

Nanoconjugates-based stem cell therapy for the management of COVID-19

D Desai, P Shende - Stem Cell Reviews and Reports, 2021 - Springer
… of COVID-19. Bioengineered nanomaterials in the form of stem cell (SC)-based
nanoconjugated therapy will be considered as an innovative approach to fight against COVID-19. …

Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19

BL Yen, ML Yen, LT Wang, KJ Liu… - Stem cells translational …, 2020 - academic.oup.com
… and cytokine storm from the novel coronavirus COVID-19, despite a lack of preclinical data.
… for COVID-19, with specific commentary on MSCT for COVID-19. Mesenchymal stem cell (…